Amylin Pharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. Amylin produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release).
^"Company Profile for Amylin Pharmaceuticals Inc (AMLN)". Retrieved 2008-10-21.
AmylinPharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery,...
Amylin, or islet amyloid polypeptide (IAPP), is a 37-residue peptide hormone. It is co-secreted with insulin from the pancreatic β-cells in the ratio of...
name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by AmylinPharmaceuticals (now a wholly owned subsidiary...
acquisition of the biotechnology company AmylinPharmaceuticals. It was agreed that Bristol Myers Squibb would acquire Amylin for $5.3 billion in cash and the...
Incorporated in March 2021, 100% owned by Biocon. In 2009, Biocon and AmylinPharmaceuticals of the United States entered into an agreement to develop, commercialise...
Veterans Administration Medical Center in New York City. It is made by AmylinPharmaceuticals and commercialized by AstraZeneca. Exenatide was approved by the...
when it agreed to buy AmylinPharmaceuticals for around US$5.3 billion in cash and pay US$1.7 billion to Eli Lilly to cover Amylin's debt and its outstanding...
Corporation: chairman of the board from 1981 to 1986; 1995–1996 AmylinPharmaceuticals: director Secretary of Defense Donald Rumsfeld and Chairman of the...
even HIV. One compound, a hormone named exendin-3, is marketed by AmylinPharmaceuticals as the drug exenatide. A study in 1996 revealed that it binds to...
Diego in the early 2000s and became Global Medical Director of AmylinPharmaceuticals. He has since returned to the United Kingdom. List of Wales national...
and Lipid Control in Patients with Lipodystrophy". Press Release. AmylinPharmaceuticals. 15 April 2011. Retrieved 27 October 2011.[permanent dead link]...
characterisation of amylin and analysis of its role in diabetes mellitus. Cooper was a founder and the chief technical officer of AmylinPharmaceuticals Inc. in California...
Research Center Keithley Instruments, Inc. Swagelok Co. Neoprobe AmylinPharmaceuticals Bridgestone Technical Center Charles River Laboratories Ashland...
Columbus, Forest Pharmaceuticals, a subsidiary of Forest Laboratories, located in Cincinnati, Patheon in Cincinnati, AmylinPharmaceuticals in West Chester...
president, government and corporate affairs and general counsel, AmylinPharmaceuticals John C. Martin, Ph.D., chairman of the board and CEO, Gilead Sciences...
patients aged 65 or older who received 12.5 or 25 mg/d of the medication. Amylin agonist analogues slow gastric emptying and suppress glucagon. They have...
evidence has been reached. This hormone stimulates growth hormone release. Amylin controls glucose homeostasis and gastric motility Glucose-dependent insulinotropic...
Ciglitazone (INN) is a thiazolidinedione. Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione...
A type of diabetic neuropathy that causes muscle weakness and wasting. Amylin A peptide thought to be involved in beta cell loss in type 2 diabetes. Angiopathy...
proposed debt swap. In April 2009, Icahn engaged in a proxy battle for Amylin. In September 2009, he offered to buy the shares of XO he did not already...
(LY-3437943) is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist...
Global Information
US$651 million (2011)[2]
US$1.87 billion (2011)[2]